Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of Lidocaine and Tetracaine Cream (CU-30101) for Facial Laser Aesthetics
NCT05793892Phase 3Completed
- Sponsor
- Cutia Therapeutics
- Start
- Apr 2023
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lidocaine 10% oropharyngeal spray, tetracaine in procedural pain, sponsored by Cutia Therapeutics. Started Apr 2023; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spraytetracaine
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT05793892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05793892.